Effectiveness and tolerability of olanzapine long-acting injection versus first-generation depot for schizophrenia: clinical outcomes

被引:2
作者
Parise, V. Fricchione [1 ]
Balletta, G. [1 ]
Addeo, L. [2 ]
Foti, M. G. [3 ]
机构
[1] Mental Hlth Ctr Australia & San Giacomo, ASL AV, Avellino, Italy
[2] ASL AV, Local Mental Hlth Unit, Lauro, AV, Italy
[3] ASL AV, Cent Biochem Lab, Avellino, Italy
关键词
D O I
10.1016/S0924-977X(11)70774-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S477 / S478
页数:2
相关论文
共 3 条
[1]   Olanzapine Long-Acting Injection A Review of its Use in the Treatment of Schizophrenia [J].
Frampton, James E. .
DRUGS, 2010, 70 (17) :2289-2313
[2]  
HILL A, 2011, BMC PSYCHIATRY, V15, P11
[3]   An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia [J].
Lauriello, John ;
Lambert, Tim ;
Andersen, Scott ;
Lin, Daniel ;
Taylor, Cindy C. ;
McDonnell, David .
JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (05) :790-799